Chemical structure:
IUPAC name:
7-[[(4S)-5,7-difluoro-3,4-dihydro-2H-chromen-4-yl]oxy]-N,N,2-trimethyl-3H-benzimidazole-5-carboxamide
CAS number:
942195-55-3
Therapy area:
Anti-ulcer
References:
IH
Status:
Under development
Mechanism of action
Tegoprazan functions as a powerful and very specific potassium-competitive acid blocker. The drug’s mechanism of action differs from that of proton-pump inhibitors since it may directly block H+/K+ ATPase in a reversible and K+ competitive manner without needing to be converted into an active state.
DISCLAIMER: PRODUCTS COVERED BY VALID & UNEXPIRED PATENTS ARE NOT OFFERED (OR) SUPPLIED FOR COMMERCIAL SCALE. THE PATENT POSITION SHOULD BE VERIFIED & LIABILITY LIES WITH THE CUSTOMER ONLY. PRODUCTS COVERED BY PATENTS ARE AVAILABLE ONLY FOR R&D USE.